Survivin (96-104)

Survivin (96-104) is a synthetic peptide corresponding to amino acid residues 96 through 104 of the human survivin protein, a member of the inhibitor of apoptosis (IAP) family. As a functionally significant region within survivin, this peptide fragment is widely recognized for its involvement in the regulation of cell division and inhibition of programmed cell death. Its sequence is highly conserved and has been studied extensively in the context of cell cycle progression, mitotic spindle formation, and apoptotic pathways. Survivin and its peptide derivatives play a pivotal role in cancer biology, making this peptide a valuable tool for diverse lines of biochemical and cellular research.

Epitope mapping: The 96-104 region of survivin is frequently utilized in epitope mapping studies to identify T-cell and antibody recognition sites. Researchers can employ this peptide to delineate immunodominant epitopes, aiding in the characterization of immune responses to survivin in various biological systems. Such mapping is instrumental in understanding the molecular interactions between survivin and components of the immune system, providing insights into antigen presentation and immune surveillance mechanisms.

Immunological assays: Survivin (96-104) serves as a critical reagent in the development and optimization of immunological assays, including ELISPOT, ELISA, and flow cytometry-based detection of survivin-specific T cells. By incorporating this peptide into assay platforms, investigators can monitor antigen-specific cellular responses, evaluate the functional status of immune effector cells, and quantify peptide-specific cytokine production. These applications are particularly relevant in studies investigating cellular immunity and antigen-specific T-cell activation.

Peptide-based vaccine research: As a representative minimal epitope, the 96-104 peptide is frequently used in preclinical research focused on peptide-based vaccine development. Its defined sequence allows for controlled studies of immunogenicity, T-cell activation, and antigen processing. By incorporating this peptide into vaccine formulations or as a target in immunization protocols, researchers can dissect the mechanisms underlying the induction of survivin-specific immune responses and evaluate strategies for enhancing antigen presentation.

Cellular signaling studies: The survivin 96-104 peptide can be employed as a molecular probe to investigate survivin-mediated signaling pathways. Its defined structure enables targeted studies on protein-protein interactions, particularly those influencing apoptosis inhibition and mitotic regulation. By introducing the peptide into cellular systems, researchers can modulate survivin-associated pathways, analyze downstream signaling events, and unravel the functional consequences of survivin activity in cell cycle control.

Antibody production and validation: Synthetic peptides derived from survivin, such as the 96-104 fragment, are widely used as immunogens for the generation of peptide-specific antibodies. These antibodies are essential tools for the detection, quantification, and localization of survivin in various experimental contexts. The peptide enables precise immunization strategies and serves as a standard for validating antibody specificity and performance in immunoblotting, immunohistochemistry, and related analytical techniques.

1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis